Anti-p200 pemphigoid: infrequent or underdiagnosed disease?

Authors

  • Karen Ginzburg Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.
  • Olga Forero Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.
  • María Emilia Candiz Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.
  • Esteban Maronna Dermatology Unit, Francisco J. Muñiz Hospital of Infectious Diseases, Autonomous City of Buenos Aires, Argentina.
  • Viviana Leiro Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.

DOI:

https://doi.org/10.47196/da.v28i1.2259

Keywords:

anti-p200 pemphigoid, laminin gamma-1, collagen type IV, subepidermal bullous disease

Abstract

Anti-p200 pemphigoid is an autoimmune subepidermal bullous disease characterized by autoantibodies targeting a 200-kDa protein localized at the lamina lucida of the basement membrane zone. The diagnosis is confirmed by immunoblot, which is a complex technique available in only few centers of the world. Therefore, there are not many reported cases of this pathology.
The incorporation of the immunohistochemical with collagen type IV technic, along with the other diagnostic methods (clinic, histopathology and immunofluorescence with salt split technic) allowed to reach at the probable diagnosis of anti-p200 pemphigoid in two patients.

Author Biographies

Karen Ginzburg, Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.

Fourth Year Resident Doctor

Olga Forero, Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.

Staff Doctor

María Emilia Candiz, Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.

Staff Doctor

Esteban Maronna, Dermatology Unit, Francisco J. Muñiz Hospital of Infectious Diseases, Autonomous City of Buenos Aires, Argentina.

Medical Pathologist

Viviana Leiro, Dermatology Unit, Francisco J. Muñiz Infectious Diseases Hospital, Autonomous City of Buenos Aires, Argentina.

Head of Unit

References

I. Kridin K, Ahmed AR. Anti-p200 Pemphigoid: a systematic review. Front Immunol. 2019;10:2466.

II. Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol. 2014;71:185-191.

III. Meijer JM, Diercks GFH, Schmidt E, Pas HH, et ál. Laboratory diagnosis and clinical profile of anti-p200 pemphigoid. JAMA Dermatol. 2016;152:897-904.

IV. García-Díez I, Martínez-Escala ME, Ishii N, Hashimoto T, et ál. Descripción de 2 casos de penfigoide anti-p200. Utilidad de una técnica inmunohistoquímica sencilla en el diagnóstico diferencial con otras enfermedades ampollosas autoinmunes. Actas Dermosifiliogr. 2017;108:1-5.

V. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, et ál. A novel subepidermal blistering disease with autoantibodies to a 200- kDa antigen of the basement membrane zone. J Invest Dermatol. 1996;106:1333-1338.

VI. Dainichi T, Koga H, Tsuji T, Ishii N, et ál. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol. 2010;37:231-238.

VII. Laufer-Britva R, Amber KT, Cohen AD, Kridin K. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review. J Eur Acad Dermatol Venereol. 2020;34:465-472.

VIII. Koga H, Ishii N, Dainichi T, Tsuruta D, et ál. An attempt to develop mouse model for anti-laminin gamma 1 pemphigoid. J Dermatol Sci. 2013;70:108-115.

IX. Vafia K, Groth S, Beckmann T, Hirose M, et ál. Pathogenicity of autoantibodies in anti-p200 pemphigoid. PLoS One. 2012;7:e41769.

X. Ansai S, Hashizume S, Kawana S, Tateishi C, et ál. Case of anti-laminin gamma-1 pemphigoid with antibody against C-terminal domain of BP180 in a patient with psoriasis vulgaris. J Dermatol. 2014;41:1031-1033.

XI. Candiz ME. Serologías por ELISA. En: Forero O, Candiz ME, Olivares L. Dermatosis ampollares autoinmunes: haga su diagnóstico. Ciudad Autónoma de Buenos Aires: Journal 2021;41-49.

XII. Rasheed VS. Anti-p200 pemphigoid: A review. Sex Transm Dis. 2021;1-6.

Published

2022-03-03

Issue

Section

Original Articles